Home

The Latest Stories

Targeted drug side effects add to cancer costs

NEW YORK (Reuters Health) - Painful rashes and other skin-related side effects of newer targeted cancer drugs may jack up treatment costs, suggests a new study.

The average cost of treating each cancer patient who came into a dermatology clinic with skin, hair and nail complaints was almost $2,000, researchers reported this week. That included expenses related to doctors' appointments ...

Tanning lotion users more likely to stay out of sun

NEW YORK (Reuters Health) - Women who use sunless tanning lotions and gels tend to cut back on outdoor sunbathing and trips to tanning beds, according to a new study from Georgia.

Researchers said the findings -- close to 40 percent of women surveyed said they had limited time in the sun because of the products -- mean that the products may be ...

Panel backs skin cancer advice for youths

NEW YORK (Reuters Health) - A government-backed expert panel joined in the fight against skin cancer on Tuesday with a proposal urging doctors to counsel fair-skinned youths about sun protection.

"The definition of fair skin is it doesn't tan very well, so stop trying!" said Dr. Virginia Moyer, head of the U.S. Preventive Services Task Force (USPSTF). "All you ...

State bans use of tanning beds by minors

LOS ANGELES (Reuters) - Minors in the state of California will no longer be allowed to use tanning beds after Governor Jerry Brown signed a bill on Sunday prohibiting anyone under the age of 18 from using ultraviolet tanning devices.

California is the first state in the nation to ban minors from using tanning beds, legislators said.

Previously, California had banned ...

California bans use of tanning beds by minors

LOS ANGELES (Reuters) - Minors in the state of California will no longer be allowed to use tanning beds after Governor Jerry Brown signed a bill on Sunday prohibiting anyone under the age of 18 from using ultraviolet tanning devices.

California is the first state in the nation to ban minors from using tanning beds, legislators said.

Previously, California had banned ...

Skin doctors head to sunnier pastures

NEW YORK (Reuters Health) - Certain areas of the United States, including the Midwest and Mountain regions, have an especially hard time holding on to dermatologists, according to a new study.

While most skin doctors who did their residencies in the South or on the West coast, for instance, stayed nearby to practice, other states lost dermatologists -- potentially creating underserved areas ...

Results show strong European consumer goods demand

LONDON/FRANKFURT (Reuters) - Some of Europe's biggest consumer goods groups defied high input costs and tepid demand to report higher sales.

Unilever, Adidas and Beiersdorf raised prices, saw strong demand in China and benefited from a warm spring in Europe.

With an array of top brands like Lipton, Knorr and Dove, Unilever was able to push its prices higher ...

Skin lesion risk seen at moderate arsenic levels

NEW YORK (Reuters Health) - High arsenic exposure is known to be a risk factor for skin cancer, but a new study suggests that even more-moderate exposure through drinking water may boost the risk of pre-cancerous skin growths.

The study, reported in the American Journal of Epidemiology, focused on an area of Bangladesh with naturally high levels of arsenic in well ...

Botox and texting may not mix: report

NEW YORK (Reuters Health) - Are you a typical American teenager who sends more than 1,000 text messages each month? If so, Botox might impair your communication prowess, suggests a new report of a 17-year-old who had the treatment for a condition that causes excessive sweating.

Doctors who use Botox said they had never heard complaints of texting impairment from ...

Botox rival shows crow's feet advantage in study

NEW YORK (Reuters) - Medicis Pharmaceutical Corp's newer anti-wrinkle drug Dysport proved significantly better than Botox at improving crow's feet in a small clinical study, a finding that could give frown lines to market leader Allergan Inc.

Allergan's Botox (onabutulinumtoxin A) was approved by U.S. regulators in 2002 to treat wrinkles between the eyebrows, while Dysport (abobutulinumtoxin ...

Previous